MPS Shares Surge 11% as FY26 Net Profit Grows to ₹173 Cr Despite No Final Dividend

Synopsis:- In a departure from recent practice, MPS Limited’s board has declined to recommend a final dividend for FY26, citing capital deployed toward the USD 16.5 million acquisition of Unbound Medicine, Inc., even as the company reported consolidated net profit of Rs. 173 crore for the year ended March 31, 2026  up 16 percent year-on-year  and cleared a full governance slate covering auditor appointments and a pending merger scheme.

A B2B learning and content solutions company used its May 15, 2026 board meeting to deliver FY26 results, a dividend decision that broke from recent precedent, and a governance overhaul spanning both internal and statutory audit appointments. The board approved the audited standalone and consolidated financial results for Q4 and the full year ended March 31, 2026, with an unmodified opinion from Walker Chandiok & Co LLP  and then chose to retain capital rather than pay out a final dividend for the first time in recent memory.

With a market capitalization of approximately Rs. 3,109.84 crore, the shares of MPS Ltd last traded at Rs. 1,818 per share, up 11.27 percent from its previous close of Rs.1,633.9. It is trading at a P/E of 16.13.

On a consolidated basis, MPS reported revenue from operations of Rs. 768 crore for FY26, up 5.7 percent year-on-year from Rs. 727 crore in FY25. Net profit for the year came in at Rs. 173 crore  a 16.3 percent increase over the prior year’s Rs. 149 crore  with consolidated basic EPS at Rs. 102.11 against Rs. 87.80 in FY25. ROCE stands at 40.9 percent and ROE at 30.5 percent, both among the stronger figures in the content-tech services space.

The standalone numbers tell a sharper growth story. Standalone revenue grew 24.8 percent year-on-year to Rs. 438 crore in FY26, with standalone PAT at Rs. 127 crore, up from Rs. 110 crore. The gap between the consolidated and standalone growth rates reflects the fact that subsidiaries, particularly the Liberate Group, consolidated from late October 2025  dragged the consolidated headline while the India-based core operations accelerated.

The consolidated segment data is where the FY26 story gets granular. Research solutions, the group’s largest business, generated revenue of Rs. 464 crore for the full year, barely moving from Rs. 459 crore in FY25  a 1 percent gain that reflects both the maturity of the publishing content services market and the base effect of a strong prior year. Segment profit, however, grew 11.1 percent to Rs. 170 crore from Rs. 153 crore, meaning Research is extracting more operating leverage from a near-flat revenue line. That is a positive signal on margin management.

Education solutions was the growth engine of the year. Revenue rose 36.3 percent to Rs. 209 crore from Rs. 153 crore in FY25, and segment profit expanded 40.9 percent to Rs. 77 crore from Rs. 55 crore. The margin expansion here  segment profit as a share of revenue improved slightly  suggests the growth was not bought through pricing concessions. This segment is now large enough to meaningfully offset weakness elsewhere in the group.

Corporate learning is the problem segment. Revenue fell 16.5 percent to Rs. 96 crore from Rs. 115 crore in FY25, and segment profit collapsed 43.5 percent to Rs. 11 crore from Rs. 20 crore. The Liberate Group, acquired by MPS Interactive Systems Limited in October 2025, sits within this segment, and the Q4 goodwill impairment of Rs. 12.93 crore was specifically tied to a reassessment of Liberate’s carrying value following its integration into the unified Liberate Global brand in April 2026.

In other words, the segment is absorbing both integration costs and a write-down within the same reporting period  which makes the degree of underlying deterioration harder to isolate. The next two quarters will determine whether corporate learning stabilises or continues to compress the consolidated margin profile.

On a standalone basis, the two-segment picture is cleaner. Research solutions grew 20.6 percent to Rs. 305 crore, with segment profit up 16.7 percent to Rs. 135 crore. Education solutions expanded 35.4 percent to Rs. 133 crore, with segment profit up 36.7 percent to Rs. 73 crore. The standalone business is firing on both segments without the drag of the corporate learning integration  which also explains why standalone revenue growth at 24.8 percent outpaced the consolidated figure of 5.7 percent so significantly.

MPS paid a final dividend of Rs. 50 per share in FY25, a payout of roughly Rs. 86 crore at the current share count. The board’s FY26 decision to withhold that payout is framed squarely around capital utilization: the Unbound Medicine, Inc. acquisition, completed on February 9, 2026, consumed cash and required external borrowings of Rs. 42 crore on top of internal accruals, for a total deal consideration of USD 16.5 million.

The capital allocation framework cited in the filing is worth noting  capital is returned to shareholders only when deployment opportunities at the company’s return thresholds are unavailable within a twelve-month horizon. That language signals management views its post-acquisition integration pipeline as a deployment opportunity, not a holding pattern.

Unbound Medicine brings a clinical medical reference platform into the MPS group, a content type that sits adjacent to the research solutions business and could feed cross-sell opportunities in the healthcare publishing vertical. The provisional goodwill recognized at acquisition stands at Rs. 123.86 crore, subject to working capital adjustment, which means a final purchase price allocation will appear in subsequent filings.

Governance: KPMG In, Walker Chandiok Staying, NCLT Watch

The board approved KPMG Assurance and Consulting Services LLP as internal auditors for three consecutive financial years starting FY27, covering both MPS Limited and its material subsidiary MPS Interactive Systems Limited. The appointment extends KPMG’s mandate uniformly across the group, replacing what was presumably a more fragmented audit oversight structure.

Walker Chandiok & Co LLP, the statutory auditor, received a second five-year term  running from the conclusion of the upcoming 56th AGM through the 61st AGM in 2031, subject to shareholder approval. The auditor’s current-year report carries an unmodified opinion.

On the corporate restructuring front, the proposed merger of ADI BPO Services Limited into MPS Limited  approved by the board on July 18, 2025 and cleared by the stock exchange in March 2026  was filed before the NCLT Chennai Bench on April 17, 2026, and remains pending a hearing date. If approved, the merger will fold ADI BPO’s residual post-demerger entity into MPS, tidying up the group structure that emerged after ADI BPO’s infrastructure and investing businesses were separated.

Business Overview

MPS Limited, incorporated in 1970 and listed on both the BSE (532440) and NSE (MPSLTD), is a B2B content and learning solutions company serving education and research clients globally. The company operates across three segments: research solutions, education solutions, and corporate learning  through a subsidiary network spanning the USA, Europe, Australia, and Germany.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post MPS Shares Surge 11% as FY26 Net Profit Grows to ₹173 Cr Despite No Final Dividend appeared first on Trade Brains.